ELAN vs. IDXX
ELAN (Elanco Animal Health Incorporated) and IDXX (IDEXX Laboratories, Inc.) are both stocks. Both are in the Healthcare sector — ELAN in Drug Manufacturers - Specialty & Generic, IDXX in Diagnostics & Research. Over the past 5 years, ELAN returned -6.28%/yr vs -3.80%/yr for IDXX. Their 0.41 correlation means their historical movements had little consistent relationship.
Performance
ELAN vs. IDXX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ELAN achieves a 16.53% return, which is significantly higher than IDXX's -17.36% return.
ELAN
- 1D
- -0.34%
- 1M
- 5.48%
- 6M
- 9.51%
- YTD
- 16.53%
- 1Y
- 91.23%
- 3Y*
- 30.12%
- 5Y*
- -6.28%
- 10Y*
- —
- ALL TIME*
- -2.53%
IDXX
- 1D
- 0.05%
- 1M
- 0.23%
- 6M
- -16.61%
- YTD
- -17.36%
- 1Y
- 4.39%
- 3Y*
- 1.65%
- 5Y*
- -3.80%
- 10Y*
- 18.10%
- ALL TIME*
- 19.97%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $130.91M | $117.38M | $140.58M | |
| $265.18M | $330.40M | $358.14M |
ELAN vs. IDXX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
ELAN Elanco Animal Health Incorporated | 16.53% | 86.87% | -18.72% | 21.93% | -56.94% | -7.47% | 4.14% | -6.60% | -2.23% |
IDXX IDEXX Laboratories, Inc. | -17.36% | 63.63% | -25.51% | 36.06% | -38.04% | 31.73% | 91.43% | 40.38% | -22.78% |
Correlation
The correlation between ELAN and IDXX is 0.45, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.45 |
Correlation (3Y) Balances recent behavior with more history. | 0.46 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.49 |
Correlation (All Time) Calculated using the full available price history since Sep 20, 2018 | 0.41 |
Fundamentals
ELAN:
$13.18B
IDXX:
$44.10B
ELAN:
-$0.48
IDXX:
$20.36
ELAN:
2.69
IDXX:
6.76
ELAN:
$4.89B
IDXX:
$4.45B
ELAN:
$2.42B
IDXX:
$2.76B
ELAN:
$755.00M
IDXX:
$1.52B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ELAN vs. IDXX — Risk / Return Rank
ELAN
IDXX
ELAN vs. IDXX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Elanco Animal Health Incorporated (ELAN) and IDEXX Laboratories, Inc. (IDXX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ELAN | IDXX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.00 | ||
| Sortino ratioReturn per unit of downside risk | +2.25 | ||
| Omega ratioGain probability vs. loss probability | 1.37 | 1.07 | +0.30 |
| Calmar ratioReturn relative to maximum drawdown | 3.56 | 0.15 | +3.41 |
| Martin ratioReturn relative to average drawdown | 10.97 | 0.25 | +10.72 |
Loading charts...
Drawdowns
ELAN vs. IDXX - Drawdown Comparison
The maximum ELAN drawdown since its inception was -78.00%, roughly equal to the maximum IDXX drawdown of -81.42%. Use the drawdown chart below to compare losses from any high point for ELAN and IDXX.
Loading charts...
Drawdown Indicators
| ELAN | IDXX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.00% | -81.42% | +3.42% |
Max Drawdown (1Y)Largest decline over 1 year | -26.23% | -31.34% | +5.11% |
Max Drawdown (3Y)Largest decline over 3 years | -56.10% | -37.41% | -18.69% |
Max Drawdown (5Y)Largest decline over 5 years | -77.81% | -54.00% | -23.81% |
Max Drawdown (10Y)Largest decline over 10 years | — | -54.00% | — |
Current DrawdownCurrent decline from peak | -28.19% | -27.08% | -1.11% |
Average DrawdownAverage peak-to-trough decline | -39.65% | -21.03% | -18.62% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.49% | 18.32% | -9.83% |
Volatility
ELAN vs. IDXX - Volatility Comparison
The current volatility for Elanco Animal Health Incorporated (ELAN) is 7.39%, while IDEXX Laboratories, Inc. (IDXX) has a volatility of 9.51%. This indicates that ELAN experiences smaller price fluctuations and is considered to be less risky than IDXX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ELAN | IDXX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.39% | 9.51% | -2.12% |
Volatility (6M)Calculated over the trailing 6-month period | 33.69% | 22.57% | +11.12% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.27% | 42.96% | +1.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.85% | 35.61% | +10.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 44.25% | 33.18% | +11.07% |
Dividends
ELAN vs. IDXX - Dividend Comparison
Neither ELAN nor IDXX has paid dividends to shareholders.
Financials
ELAN vs. IDXX - Financials Comparison
This section allows you to compare key financial metrics between Elanco Animal Health Incorporated and IDEXX Laboratories, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ELAN vs. IDXX - Profitability Comparison
ELAN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Elanco Animal Health Incorporated reported a gross profit of 785.00M and revenue of 1.37B. Therefore, the gross margin over that period was 57.3%.
IDXX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, IDEXX Laboratories, Inc. reported a gross profit of 722.74M and revenue of 1.14B. Therefore, the gross margin over that period was 63.4%.
ELAN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Elanco Animal Health Incorporated reported an operating income of 307.00M and revenue of 1.37B, resulting in an operating margin of 22.4%.
IDXX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, IDEXX Laboratories, Inc. reported an operating income of 362.59M and revenue of 1.14B, resulting in an operating margin of 31.8%.
ELAN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Elanco Animal Health Incorporated reported a net income of 57.00M and revenue of 1.37B, resulting in a net margin of 4.2%.
IDXX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, IDEXX Laboratories, Inc. reported a net income of 278.45M and revenue of 1.14B, resulting in a net margin of 24.4%.
Frequently Asked Questions
ELAN and IDXX have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IDXX has higher volatility (9.51%) compared to ELAN (7.39%). In terms of maximum drawdown, ELAN dropped -78.00% vs IDXX's -81.42%.
ELAN currently has the higher Sharpe Ratio (2.11 vs 0.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ELAN and IDXX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer